BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23278352)

  • 1. mTOR: at the crossroads of aging, chaperones, and Alzheimer's disease.
    Gouras GK
    J Neurochem; 2013 Mar; 124(6):747-8. PubMed ID: 23278352
    [No Abstract]   [Full Text] [Related]  

  • 2. Dysregulated mTOR-dependent signaling in neurodegeneration or carcinogenesis: implication for Alzheimer's disease and brain tumors.
    Wang S; Wu J; Nie SD; Bereczki E; Pei JJ
    J Alzheimers Dis; 2013; 37(3):495-505. PubMed ID: 23948902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease.
    Galvan V; Hart MJ
    Biochim Biophys Acta; 2016 May; 1862(5):992-1007. PubMed ID: 26639036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
    Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
    J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR in cerebrovascular disease.
    Van Skike CE; Galvan V
    Aging (Albany NY); 2019 Mar; 11(5):1331-1332. PubMed ID: 30867339
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of rapamycin and TOR on aging and memory: implications for Alzheimer's disease.
    Santos RX; Correia SC; Cardoso S; Carvalho C; Santos MS; Moreira PI
    J Neurochem; 2011 Jun; 117(6):927-36. PubMed ID: 21447003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression analysis of mTOR pathway: association with human longevity.
    Passtoors WM; Beekman M; Deelen J; van der Breggen R; Maier AB; Guigas B; Derhovanessian E; van Heemst D; de Craen AJ; Gunn DA; Pawelec G; Slagboom PE
    Aging Cell; 2013 Feb; 12(1):24-31. PubMed ID: 23061800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging.
    Das A; Reis F; Maejima Y; Cai Z; Ren J
    Oxid Med Cell Longev; 2017; 2017():6018675. PubMed ID: 28770023
    [No Abstract]   [Full Text] [Related]  

  • 9. Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease.
    Yates SC; Zafar A; Hubbard P; Nagy S; Durant S; Bicknell R; Wilcock G; Christie S; Esiri MM; Smith AD; Nagy Z
    Acta Neuropathol Commun; 2013 May; 1():3. PubMed ID: 24252508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR signalling: the molecular interface connecting metabolic stress, aging and cardiovascular diseases.
    Yang Z; Ming XF
    Obes Rev; 2012 Dec; 13 Suppl 2():58-68. PubMed ID: 23107260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do extracellular chaperone proteins in plasma have potential as Alzheimer's disease biomarkers?
    Thambisetty M
    Biomark Med; 2010 Dec; 4(6):831-4. PubMed ID: 21133702
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebrovascular dysfunction links aging to neurological disease.
    Van Skike CE; Galvan V
    Aging (Albany NY); 2020 Jul; 12(14):13847-13848. PubMed ID: 32756010
    [No Abstract]   [Full Text] [Related]  

  • 13. [TOR-centric concept of regulation mitogenic, metabolic and energetic signal processing in cell].
    Zubova SG; Shitikova ZhV; Pospelova TV
    Tsitologiia; 2012; 54(8):589-602. PubMed ID: 23074850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
    Kulnane LS; Lamb BT
    Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR and Aging: An Old Fashioned Dress.
    Stallone G; Infante B; Prisciandaro C; Grandaliano G
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31174250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminum disruption of calcium homeostasis and signal transduction resembles change that occurs in aging and Alzheimer's disease.
    Walton JR
    J Alzheimers Dis; 2012; 29(2):255-73. PubMed ID: 22330830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular environment facilitates protein accumulation in aged rat hippocampus.
    Paz Gavilán M; Vela J; Castaño A; Ramos B; del Río JC; Vitorica J; Ruano D
    Neurobiol Aging; 2006 Jul; 27(7):973-82. PubMed ID: 15964666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clusterin and Alzheimer's disease.
    Calero M; Rostagno A; Frangione B; Ghiso J
    Subcell Biochem; 2005; 38():273-98. PubMed ID: 15709484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging 2018.
    Das A; Reis F; Mishra PK
    Oxid Med Cell Longev; 2019; 2019():9692528. PubMed ID: 30863483
    [No Abstract]   [Full Text] [Related]  

  • 20. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus.
    Lukiw WJ
    Neuroreport; 2007 Feb; 18(3):297-300. PubMed ID: 17314675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.